(Q46789879)

English

Triple nucleoside reverse transcriptase inhibitor- vs. nonnucleoside reverse transcriptase inhibitor-containing regimens as first-line therapy: efficacy and durability in a prospective cohort of French HIV-infected patients.

scientific article published in November 2005

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16268820%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Triple nucleoside reverse transcriptase inhibitor- vs. nonnucleoside reverse transcriptase inhibitor-containing regimens as first-line therapy: efficacy and durability in a prospective cohort of French HIV-infected patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16268820%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Cyrille Delpierre

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16268820%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

L Cuzin

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16268820%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

P Pugliese

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16268820%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

F Bugnon

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16268820%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

E Cua

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16268820%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

E Billaud

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16268820%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

P Massip

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16268820%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

F Raffi

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16268820%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

P Dellamonica

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16268820%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 November 2005

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16268820%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16268820%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16268820%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16268820%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

388-395

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16268820%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

Durability and predictors of success of highly active antiretroviral therapy for ambulatory HIV-infected patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00315.X

21 January 2018

Virological suppression at 6 months is related to choice of initial regimen in antiretroviral-naive patients: a cohort study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00315.X

21 January 2018

The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00315.X

21 January 2018

A dose-ranging study to evaluate the safety and efficacy of abacavir alone or in combination with zidovudine and lamivudine in antiretroviral treatment-naive subjects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00315.X

21 January 2018

A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00315.X

21 January 2018

Triple-nucleoside regimens versus efavirenz-containing regimens for the initial treatment of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00315.X

21 January 2018

Which nucleoside and nucleotide backbone combinations select for the K65R mutation in HIV-1 reverse transcriptase

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00315.X

21 January 2018

Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: comparison of cohort studies with randomized trials. EuroSIDA, the French Hospital Database on HIV and the Swiss HIV Cohort Study Groups

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00315.X

21 January 2018

Determinants of survival following HIV-1 seroconversion after the introduction of HAART.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00315.X

21 January 2018

Distinguishing efficacy, individual effectiveness and population effectiveness of therapies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00315.X

21 January 2018

Duration of Highly Active Antiretroviral Therapy Regimens

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00315.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46789879&oldid=2217071152"